ReviewCardiovascular diabetology2023

The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction.

Ulrich Kintscher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.